{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:36:53Z","timestamp":1781195813798,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK42086"],"award-info":[{"award-number":["P30 DK42086"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 DK090152"],"award-info":[{"award-number":["K08 DK090152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10620-019-5474-4","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T10:03:59Z","timestamp":1549447439000},"page":"1938-1944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"64","author":[{"given":"Jeffrey D.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Gulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Pekow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"5474_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","volume":"21","author":"P Dandona","year":"2007","unstructured":"Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens. 2007;21:20\u201327.","journal-title":"J Hum Hypertens"},{"key":"5474_CR2","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","volume":"62","author":"M Ruiz-Ortega","year":"2002","unstructured":"Ruiz-Ortega M, Ruperez M, Lorenzo O, et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl. 2002;62:S12\u2013S22.","journal-title":"Kidney Int Suppl"},{"key":"5474_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0162-3109(96)00160-9","volume":"36","author":"M Fukuzawa","year":"1997","unstructured":"Fukuzawa M, Satoh J, Sagara M, et al. Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-alpha in vitro and in vivo. Immunopharmacology. 1997;36:49\u201355.","journal-title":"Immunopharmacology"},{"key":"5474_CR4","doi-asserted-by":"publisher","first-page":"G255","DOI":"10.1152\/ajpgi.00264.2009","volume":"298","author":"T Mizushima","year":"2010","unstructured":"Mizushima T, Sasaki M, Ando T, et al. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G255\u2013G266.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5474_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3164\/jcbn.10-41","volume":"48","author":"S Tanida","year":"2011","unstructured":"Tanida S, Mizoshita T, Mizushima T, et al. Involvement of oxidative stress and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in inflammatory bowel disease. J Clin Biochem Nutr. 2011;48:112\u2013116.","journal-title":"J Clin Biochem Nutr"},{"key":"5474_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/0016-5085(90)91088-N","volume":"98","author":"R Jaszewski","year":"1990","unstructured":"Jaszewski R, Tolia V, Ehrinpreis MN, et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn\u2019s colitis. Gastroenterology. 1990;98:1543\u20131548.","journal-title":"Gastroenterology"},{"key":"5474_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00054725-200409000-00007","volume":"10","author":"D Wengrower","year":"2004","unstructured":"Wengrower D, Zanninelli G, Zannineli G, et al. Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. Inflamm Bowel Dis. 2004;10:536\u2013545.","journal-title":"Inflamm Bowel Dis"},{"key":"5474_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.surg.2008.03.043","volume":"144","author":"H Koga","year":"2008","unstructured":"Koga H, Yang H, Adler J, Zimmermann EM, Teitelbaum DH. Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment. Surgery. 2008;144:259\u2013268.","journal-title":"Surgery"},{"key":"5474_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00011-009-0053-3","volume":"58","author":"JJ Byrnes","year":"2009","unstructured":"Byrnes JJ, Gross S, Ellard C, Connolly K, Donahue S, Picarella D. Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflamm Res. 2009;58:819\u2013827.","journal-title":"Inflamm Res"},{"key":"5474_CR10","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s10620-011-1651-9","volume":"56","author":"M Okawada","year":"2011","unstructured":"Okawada M, Koga H, Larsen SD, et al. Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis. Dig Dis Sci. 2011;56:2553\u20132565.","journal-title":"Dig Dis Sci"},{"key":"5474_CR11","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s10620-013-2825-4","volume":"58","author":"R Sueyoshi","year":"2013","unstructured":"Sueyoshi R, Ignatoski KMW, Daignault S, Okawada M, Teitelbaum DH. Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model. Dig Dis Sci. 2013;58:3165\u20133177.","journal-title":"Dig Dis Sci"},{"key":"5474_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.lfs.2013.11.005","volume":"95","author":"C Lee","year":"2014","unstructured":"Lee C, Chun J, Hwang SW, Kang SJ, Im JP, Kim JS. Enalapril inhibits nuclear factor-\u03baB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Life Sci. 2014;95:29\u201339.","journal-title":"Life Sci"},{"key":"5474_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cyto.2015.03.017","volume":"74","author":"S Arumugam","year":"2015","unstructured":"Arumugam S, Sreedhar R, Thandavarayan RA, et al. Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium. Cytokine. 2015;74:305\u2013312.","journal-title":"Cytokine"},{"key":"5474_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.pharep.2014.12.011","volume":"67","author":"GCB Guerra","year":"2015","unstructured":"Guerra GCB, Ara\u00fajo AA, Lira GA, et al. Telmisartan decreases inflammation by modulating TNF-\u03b1, IL-10, and RANK\/RANKL in a rat model of ulcerative colitis. Pharmacol Rep. 2015;67:520\u2013526.","journal-title":"Pharmacol Rep"},{"key":"5474_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.taap.2013.04.026","volume":"271","author":"MM Nagib","year":"2013","unstructured":"Nagib MM, Tadros MG, ElSayed MI, Khalifa AE. Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats. Toxicol Appl Pharmacol. 2013;271:106\u2013113.","journal-title":"Toxicol Appl Pharmacol"},{"key":"5474_CR16","doi-asserted-by":"publisher","first-page":"e97193","DOI":"10.1371\/journal.pone.0097193","volume":"9","author":"HH Arab","year":"2014","unstructured":"Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS ONE. 2014;9:e97193.","journal-title":"PLoS ONE"},{"key":"5474_CR17","doi-asserted-by":"publisher","first-page":"27552","DOI":"10.1038\/srep27552","volume":"6","author":"Y Shi","year":"2016","unstructured":"Shi Y, Liu T, He L, et al. Activation of the renin\u2013angiotensin system promotes colitis development. Sci Rep. 2016;6:27552.","journal-title":"Sci Rep"},{"key":"5474_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","volume":"118","author":"R Bataller","year":"2000","unstructured":"Bataller R, Gin\u00e8s P, Nicol\u00e1s JM, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology. 2000;118:1149\u20131156.","journal-title":"Gastroenterology"},{"key":"5474_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1006\/jmcc.1997.0435","volume":"29","author":"SE Campbell","year":"1997","unstructured":"Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol. 1997;29:1947\u20131958.","journal-title":"J Mol Cell Cardiol"},{"key":"5474_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1681\/ASN.2010040384","volume":"22","author":"C R\u00fcster","year":"2011","unstructured":"R\u00fcster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol. 2011;22:1189\u20131199.","journal-title":"J Am Soc Nephrol"},{"key":"5474_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1478-3231.2009.01973.x","volume":"29","author":"KE Corey","year":"2009","unstructured":"Corey KE, Shah N, Misdraji J, et al. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int. 2009;29:748\u2013753.","journal-title":"Liver Int"},{"key":"5474_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1755-1536-7-5","volume":"7","author":"D Bettenworth","year":"2014","unstructured":"Bettenworth D, Rieder F. Medical therapy of stricturing Crohn\u2019s disease: what the gut can learn from other organs\u2014a systematic review. Fibrogenesis Tissue Repair. 2014;7:5.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"5474_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00408-012-9410-z","volume":"190","author":"M Couluris","year":"2012","unstructured":"Couluris M, Kinder BW, Xu P, Gross-King M, Krischer J, Panos RJ. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. Lung. 2012;190:523\u2013527.","journal-title":"Lung"},{"key":"5474_CR24","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","volume":"105","author":"J D\u00edez","year":"2002","unstructured":"D\u00edez J, Querejeta R, L\u00f3pez B, Gonz\u00e1lez A, Larman M, Mart\u00ednez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002;105:2512\u20132517.","journal-title":"Circulation"},{"key":"5474_CR25","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","volume":"19","author":"O Gross","year":"2004","unstructured":"Gross O, Schulze-Lohoff E, Koepke M-L, et al. Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis. Nephrol Dial Transpl. 2004;19:1716\u20131723.","journal-title":"Nephrol Dial Transpl"},{"key":"5474_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1155\/2012\/628268","volume":"26","author":"D Wengrower","year":"2012","unstructured":"Wengrower D, Zanninelli G, Latella G, et al. Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats. Can J Gastroenterol. 2012;26:33\u201339.","journal-title":"Can J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-5474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-5474-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-5474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:20:42Z","timestamp":1589725242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-5474-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["5474"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-5474-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"15 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}